Sanj K. Patel
CHAIRMAN & CEO at Kiniksa Pharmaceuticals International plc
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Kiniksa Pharmaceuticals International plc, 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Kiniksa Pharmaceuticals International plc June 3, 202597.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 4, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +145,763 | $17.92 | $2,612,073 |
| Nov 4, 2026 | Kiniksa Pharmaceuticals International plc | Open-market sale | −1,460 | $92.35 | $134,831 |
| Nov 4, 2026 | Kiniksa Pharmaceuticals International plc | Open-market sale | −11,335 | $93.54 | $1,060,276 |
| Nov 4, 2026 | Kiniksa Pharmaceuticals International plc | Open-market sale | −81,742 | $94.20 | $7,700,096 |
| Nov 4, 2026 | Kiniksa Pharmaceuticals International plc | Open-market sale | −29,845 | $95.48 | $2,849,601 |
| Nov 4, 2026 | Kiniksa Pharmaceuticals International plc | Open-market sale | −26,918 | $96.05 | $2,585,474 |
| Nov 3, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +89,089 | $8.83 | $786,656 |
| Nov 3, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +41,237 | $17.92 | $738,967 |
| Nov 3, 2026 | Kiniksa Pharmaceuticals International plc | Open-market sale | −1,214 | $90.77 | $110,195 |
| Nov 3, 2026 | Kiniksa Pharmaceuticals International plc | Open-market sale | −68,664 | $92.70 | $6,365,153 |
| Nov 3, 2026 | Kiniksa Pharmaceuticals International plc | Open-market sale | −145,708 | $93.53 | $13,628,069 |
| Nov 3, 2026 | Kiniksa Pharmaceuticals International plc | Open-market sale | −4,584 | $94.25 | $432,042 |
| Nov 2, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +53,381 | $8.83 | $471,354 |
| Nov 2, 2026 | Kiniksa Pharmaceuticals International plc | Open-market sale | −38,364 | $91.03 | $3,492,275 |
| Nov 2, 2026 | Kiniksa Pharmaceuticals International plc | Open-market sale | −24,188 | $91.83 | $2,221,184 |
Questions about Sanj K. Patel
What boards is Sanj K. Patel on?
Sanj K. Patel sits on the board of Kiniksa Pharmaceuticals International plc.
What company is Sanj K. Patel the CEO of?
Sanj K. Patel is CHAIRMAN & CEO of Kiniksa Pharmaceuticals International plc.
How long has Sanj K. Patel served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.